TRAIL receptor I (<it>DR4</it>) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients

by Körner Christian, Riesner Katarina, Krämer Benjamin, Eisenhardt Marianne, Glässner Andreas, Wolter Franziska, Berg Thomas, Müller Tobias, Sauerbruch Tilman, Nattermann Jacob, Spengler Ulrich, Nischalke Hans
Published 2012-03-01

Effects of common haplotypes of the ileal sodium dependent bile acid transporter gene on the development of sporadic and familial colorectal cancer: A case control study

by Friedrichs Nicolaus, Plassmann Dominik, Schulte-Witte Hildegard, Becker Ursula, Keppeler Hildegard, Lamberti Christoph, Jungck Matthias, Grünhage Frank, Buettner Reinhard, Aretz Stefan, Sauerbruch Tilman, Lammert Frank
Published 2008-07-01

Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma

by Schmiedel, Alexandra, Sommer, Thorsten, Schild, Hans Heinz, Strunk, Holger, von Ruecker, Alexander, Franchy, Christian, Müller, Stefan, Albers, Peter, Sievers, Elisabeth, Märten, Angela, Sauerbruch, Tilman, Schmidt-Wolf, Ingo G.H.
Published 2006-02-01

Tumormikroenvironment in Neuroendokrinen Tumoren (NET) des gastroenteropankreatischen Systems

by Skupin, Julian
Published 2013